DEFA14A ·Filed Mar 18, 2026

BSX

BOSTON SCIENTIFIC CORP
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0000885725-26-000027
Proxy solicitation materials
Actionable Insight • Neutral

Traders should await the full proxy filing to assess potential governance risks or changes in leadership/compensation that could influence investor sentiment. Monitor for any activist shareholder initiatives or dissident nominations once the document is available.

DirectionNeutral
Confidencelow
Horizonweeks
Final — all horizons settled through T+60d
BSX ▼ -33.12% at T+60d
NEUTRAL call ✗ call lost -33.12% · α vs SPY -47.46% · entry $69.88 → $46.74
Entry anchored
Mar 18, 03:59 PM ET
via exchange tick
T+1d
-0.59%
call -0.59% · α +1.15%
$69.47
settled 7mo ago
T+5d
+0.37%
call +0.37% · α +2.58%
$70.14
settled 6mo ago
T+20d
-8.10%
call -8.10% · α -15.72%
$64.22
settled 6mo ago
T+60d
-33.12%
call -33.12% · α -47.46%
$46.74
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. This DEFA14A filing by Boston Scientific Corp (BSX) relates to a proxy statement for a shareholder vote, likely concerning director elections, executive compensation, or other corporate governance matters. Without access to the full filing, specific details on proposals or activist involvement cannot be determined.

Key Facts

  • Filing type DEFA14A indicates this is a definitive proxy statement for a shareholder meeting.
  • Typically includes information on director nominees, executive compensation, and shareholder proposals.
  • No document content available to confirm specific agenda items or voting recommendations.
  • Recent insider buying observed in congressional trades, though not necessarily linked to this filing.

Financial Impact

Not specified

Risk Factors

  • Lack of transparency due to missing filing content limits ability to assess material governance developments.
  • Potential for unexpected shareholder proposals or management controversies not yet disclosed.

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

Report based on filing metadata.

17 reports for BSX
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+20▲ +9.24%Aug 26, 2026
Filters
Rows
Reports for BSX — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Court Ruling
NEUTRAL ★ 2/10
$48.30 $43.88▼ −9.15%▼ −8.96%$43.23 (−10.50%)
Aug 26, 2026
5w ago
8-K
BEARISH ★ 6/10
$48.17 $43.72▲ +9.24%▲ +10.44%$43.23 (+10.26%)
Aug 22, 2026
5w ago
Institutional Cluster
MIXED ★ 6/10
$49.01 $44.92▼ −8.35%▼ −9.66%$43.23 (−11.79%)
Aug 7, 2026
8w ago
Insider Cluster
MIXED ★ 6/10
$49.31 $47.80▼ −3.06%▼ −2.67%$43.23 (−12.33%)
Aug 7, 2026
8w ago
Insider Cluster
MIXED ★ 5/10
$49.31 $47.80▼ −3.06%▼ −2.67%$43.23 (−12.33%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$47.74 $48.37▲ +1.32%▲ +1.92%$43.23 (−9.45%)
Jul 29, 2026
9w ago
8-K
BEARISH ★ 7/10
$46.04 $48.17▼ −4.63%▲ +0.39%$43.23 (+6.10%)
Jul 27, 2026
9w ago
8-K
NEUTRAL ★ 4/10
$46.06 $49.86▲ +8.25%▲ +4.87%$43.23 (−6.14%)
Jul 27, 2026
9w ago
Court Ruling
BULLISH ★ 7/10
$45.51 $49.01▲ +7.69%▲ +4.39%$43.23 (−5.01%)
Jul 10, 2026
12w ago
Court Ruling
NEUTRAL ★ 2/10
$44.77 $49.30▲ +10.11%▲ +7.69%$43.23 (−3.44%)
Showing 10 of 17

US Market Status

Market Closed — Opens in 1h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access